Reflow Medical, Inc. ignites a medical revolution with the first patient enrollments in a pilot study named “DEEPER CORONARY.” This pivotal research, set to radically change the treatment of coronary in-stent restenosis (ISR), a notorious villain in cardiovascular health, is now underway at three prestigious centers across New Zealand. DEEPER CORONARY, officially known as the […]
Reflow Medical has obtained commercial clearance from the US Food and Drug Administration (FDA) for its coraCatheters range of microcatheters. These specialized devices are designed to access and navigate complex and challenging lesions during percutaneous coronary interventions. The coraCatheters series is the latest addition to the portfolio of the American medical equipment manufacturer, which already […]
